Delivery Order SPE2DX22D0029-SPE2D826F08NP
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $46,475.04 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 29, 2025, with a completion deadline of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The...
- The U.S. Defense Logistics Agency Medical Supply Chain issued a delivery order valued at $8,457.68 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 10, 2025, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued at $999,999,999.00 through December 2026. The contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,634.88 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,177.85 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on November 3, 2025, with an ultimate completion date of November 4, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $79,064.32 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order, which was not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The work will be...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,333.30 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with completion scheduled for December 2, 2025. This competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the company's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $42,468.57 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 8, 2025, with completion expected by December 9, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from the...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $79,379.64 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which received no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The contract will...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 11, 2025, with a ceiling value of $2,220.35. This firm fixed-price delivery order, designated as a non-competitive child contract, is set to be completed by December 12, 2025, and represents a specific pharmaceutical or medical supply fulfillment from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,724.80 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 2, 2025, with an ultimate completion date of December 3, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D826F08NPDelivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $4,977.12 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, which is not a set-aside contract, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX and valued at $999,999,999.00 through December 2026. The company's corporate office, located in Conshohocken, Pennsylvania, serves as the place of performance for this order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, supplies a comprehensive range of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems. The company's portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order is part of AmerisourceBergen's extensive federal contract portfolio with DLA and represents the company's ongoing role as a critical vendor in the Department of Defense's pharmaceutical supply chain, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 12/4/25 |